{"id":5410,"date":"2024-12-07T15:12:57","date_gmt":"2024-12-07T14:12:57","guid":{"rendered":"https:\/\/uuinvest.se\/?p=5410"},"modified":"2024-12-07T15:12:57","modified_gmt":"2024-12-07T14:12:57","slug":"international-research-collaboration-brings-hope-for-glioblastoma-treatment","status":"publish","type":"post","link":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/","title":{"rendered":"International research collaboration brings hope for glioblastoma treatment"},"content":{"rendered":"

[vc_row][vc_column][vc_empty_space height=”200px” el_class=”single-intro-space”][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/6″][\/vc_column][vc_column width=”2\/3″ offset=”vc_col-lg-7 vc_col-md-7 vc_col-xs-12″][vc_btn title=”Tillbaka” style=”custom” custom_background=”rgba(255,255,255,0.01)” custom_text=”#f87052″ shape=”square” align=”left” src=”“https:\/\/uuinvest.se\/wp-content\/uploads\/2021\/02\/left-arrow.png“” el_class=”back-btn” link=”url:https%3A%2F%2Fuuinvest.se%2Fen%2Fnews%2F|title:Aktuellt|”][vc_custom_heading text=”International research collaboration brings hope for glioblastoma treatment” font_container=”tag:h1|text_align:left|color:%23021626″ use_theme_fonts=”yes” css=”” el_class=”single-title”][vc_column_text css_animation=”none” css=”” el_class=”single-intro”]A challenging and demanding journey awaits the newly founded company, Mesenkia Therapeutics, as it begins work to hopefully offer a completely new way to clinically treat glioblastoma \u2013 the most common and aggressive type of brain cancer. UU Invest is investing in the company, which is now preparing the clinical trials required to develop and approve a new drug. A drug that is hoped to increase the lifespan of affected patients.[\/vc_column_text][vc_single_image image=”5404″ img_size=”full” css=””][vc_column_text css_animation=”none” css=”” el_class=”single-intro”]Compared to the treatment of many other cancer diagnoses, where new research has enabled significant progress and drastically improved survival rates, there is currently no targeted treatment with similar advancements for glioblastoma. This aggressive cancer type remains as difficult to treat today as it was before. Only marginal progress has been made. This may now change thanks to a long-standing research collaboration between professors Bengt Westermark and Carl-Henrik Heldin from Uppsala university and Professor Kohei Miyazono and his colleague Ryo Tanabe from the University of Tokyo.[\/vc_column_text][vc_column_text css_animation=”none” css=”” el_class=”single-intro”]<\/p>\n

At the Core \u2013 An Antibody<\/strong><\/h2>\n

\u2013 It\u2019s a challenging and demanding task ahead, but as I see it, it is our duty as researchers to try when we see the great potential we see here. Not trying would be wrong. If everything goes according to plan, it would be fantastic to offer a new treatment for this patient group, says Bengt Westermark, Professor at the Department of Immunology, Genetics, and Pathology at Uppsala university.<\/p>\n

Years of research lie behind this breakthrough. The hopes for a new drug are based on the discovery of a protein on the surface of cancer cells. Building on this discovery, the research team has developed an antibody that targets the protein and appears to inhibit tumor growth.[\/vc_column_text][vc_column_text css_animation=”none” css=”” el_class=”single-intro”]<\/p>\n

Difficult to Cure \u2013 But Possible to Extend Lifespan<\/strong><\/h2>\n

\u2013 This is a major breakthrough in our research. For the first time, we have been able to use targeted therapy against glioblastoma cells. Hopefully, we have also found a way not only to inhibit cancer cell growth but also to activate the immune system. This could potentially allow for the addition of other relevant immunotherapies to further suppress growth \u2013 and thus increase the lifespan of affected patients even more. However, it is important to remember that this is an extremely challenging tumor type to treat. We probably cannot cure the disease, but we can hopefully extend the patient’s life, says Bengt.<\/p>\n

 <\/p>\n

Mesenkia Takes the Work Forward<\/strong><\/h2>\n

The research that underpins this breakthrough has been ongoing for many years and it will take time before the findings reach affected patients. However, work to accelerate the process has already started, with the newly founded company Mesenkia taking the lead.<\/p>\n

 <\/p>\n

\u2013 The first challenge for the company is to finance and conduct the clinical trials required to get the drug approved. This work requires significant resources. Another important task is to secure the patents needed for future drug production. This is also a major and extensive undertaking. We are already underway, and we hope the clinical trial results will show promising outcomes. If everything goes as we hope and believe, a new treatment could be rolled out on a large scale, says Carl-Henrik Heldin, Professor at the Department of Medical Biochemistry and Microbiology, Biomedical Center (BMC) at Uppsala university.[\/vc_column_text][vc_column_text css_animation=”none” css=”” el_class=”single-intro”]<\/p>\n

Collaboration \u2013 A Recipe for Success<\/strong><\/h2>\n

For both Bengt and Carl-Henrik, the research breakthrough and the effort to move the research forward to make a difference for patients are significant. Working with researchers from other countries is seen as part of the success.<\/p>\n

The two researchers have collaborated for almost 50 years and are both colleagues and good friends.<\/p>\n

 <\/p>\n

\u2013 It\u2019s about trust between researchers. Collaborations. Working internationally is an important and enjoyable aspect of our role as researchers. We work together and often become very good friends. Collaborations are also part of what it means to be a researcher, something I value and believe helps us move forward toward new important knowledge, says Bengt, who is often described as a leading figure in glioblastoma research, with many active research groups tied to his work at the Rudbeck Laboratory.<\/p>\n

 <\/p>\n

Carl-Henrik shares the same view. Collaborations lead to good research.<\/p>\n

 <\/p>\n

\u2013 I agree with Bengt about the value of collaboration between researchers. That\u2019s how it works. Our field spans the entire world, and the focus isn\u2019t just on what we ourselves are doing. We participate and contribute internationally in numerous research processes. Researchers aren\u2019t typically introverted people. Research is often an interactive endeavor where you share results. Being part of large research contexts and contributing to solutions is both an enjoyable and important aspect of being a researcher, says Carl-Henrik.<\/p>\n

 <\/p>\n

Visit Mesenkia Therapeutics<\/a>\u00a0for more information about the company, or email the CEO, Moa Fransson, at moa.fransson@mesenkia.com.<\/a>[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_hidden-sm vc_hidden-xs”][\/vc_column][\/vc_row][vc_row][vc_column width=”2\/3″ el_class=”author-column” offset=”vc_col-lg-offset-0 vc_col-lg-2 vc_col-md-offset-0 vc_col-md-2 vc_col-sm-offset-2 vc_col-xs-12″][\/vc_column][vc_column width=”2\/3″ offset=”vc_col-lg-offset-0 vc_col-lg-7 vc_col-md-offset-0 vc_col-md-7 vc_col-sm-offset-2 vc_col-xs-12″][vc_column_text el_class=”single-content”][\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_hidden-sm vc_hidden-xs”][\/vc_column][\/vc_row][vc_row el_class=”next-prev-row”][vc_column]

<\/div>[\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1612554281196{background-color: #021626 !important;}” el_class=”posts-row”][vc_column][vc_row_inner][vc_column_inner width=”1\/2″ offset=”vc_col-xs-6″][vc_custom_heading text=”Aktuellt” font_container=”tag:h2|text_align:left|color:%23ffffff” use_theme_fonts=”yes” el_class=”ft-fm-hn heading-posts”][\/vc_column_inner][vc_column_inner el_class=”select-column” width=”1\/2″ offset=”vc_col-xs-6″][vc_raw_html]PHAgY2xhc3M9ImJlZm9yZS1zZWxlY3QiPlZpc2E6PC9wPjxkaXYgY2xhc3M9ImN1c3RvbS1zZWxlY3QiPjwvZGl2Pg0K[\/vc_raw_html][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”chnage-posts”][vc_column_inner][vc_basic_grid post_type=”post” max_items=”-1″ style=”load-more” items_per_page=”8″ show_filter=”yes” element_width=”3″ gap=”10″ filter_style=”dropdown” filter_default_title=”Visa allt” filter_align=”right” filter_color=”sandy_brown” filter_size=”lg” item=”171″ btn_title=”Se fler” btn_style=”custom” btn_custom_background=”#ffffff” btn_custom_text=”#f87052″ btn_size=”lg” btn_custom_onclick=”true” grid_id=”vc_gid:1733313207782-4a4d45e9-5115-9″ filter_source=”category” taxonomies=”6, 5, 9, 7, 4, 11″ el_class=”my-grid-posts” btn_el_id=”loadMoreBtn” btn_custom_onclick_code=”makeCount()” el_id=”myPosts”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer. The startup is preparing clinical trials to create a drug aimed at extending patients’ lives.<\/p>\n","protected":false},"author":10,"featured_media":5404,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39,43],"tags":[],"class_list":["post-5410","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-knowledge","category-news","category-39","category-43","description-off"],"acf":[],"yoast_head":"\nInternational research collaboration brings hope for glioblastoma treatment Uppsala University Invest<\/title>\n<meta name=\"description\" content=\"Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"International research collaboration brings hope for glioblastoma treatment Uppsala University Invest\" \/>\n<meta property=\"og:description\" content=\"Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Uppsala University Invest\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-07T14:12:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/uuinvest.se\/wp-content\/uploads\/2024\/12\/croppeduu-1024x1004.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1004\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Victoria Wouda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Victoria Wouda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/\"},\"author\":{\"name\":\"Victoria Wouda\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/#\\\/schema\\\/person\\\/ffa099f10109b4236ca521941d43063e\"},\"headline\":\"International research collaboration brings hope for glioblastoma treatment\",\"datePublished\":\"2024-12-07T14:12:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/\"},\"wordCount\":1259,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/uuinvest.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/croppeduu.jpg\",\"articleSection\":[\"KNOWLEDGE\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/\",\"url\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/\",\"name\":\"International research collaboration brings hope for glioblastoma treatment Uppsala University Invest\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/uuinvest.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/croppeduu.jpg\",\"datePublished\":\"2024-12-07T14:12:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/#\\\/schema\\\/person\\\/ffa099f10109b4236ca521941d43063e\"},\"description\":\"Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/uuinvest.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/croppeduu.jpg\",\"contentUrl\":\"https:\\\/\\\/uuinvest.se\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/croppeduu.jpg\",\"width\":2000,\"height\":1961,\"caption\":\"me\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"International research collaboration brings hope for glioblastoma treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/#website\",\"url\":\"https:\\\/\\\/uuinvest.se\\\/\",\"name\":\"Uppsala University Invest\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/uuinvest.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/uuinvest.se\\\/#\\\/schema\\\/person\\\/ffa099f10109b4236ca521941d43063e\",\"name\":\"Victoria Wouda\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/561e9935b32965fd910374121e60aba0274902d85a35667b02d2e865f0deca86?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/561e9935b32965fd910374121e60aba0274902d85a35667b02d2e865f0deca86?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/561e9935b32965fd910374121e60aba0274902d85a35667b02d2e865f0deca86?s=96&d=mm&r=g\",\"caption\":\"Victoria Wouda\"},\"url\":\"https:\\\/\\\/uuinvest.se\\\/en\\\/author\\\/victoriawouda\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"International research collaboration brings hope for glioblastoma treatment Uppsala University Invest","description":"Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/","og_locale":"en_US","og_type":"article","og_title":"International research collaboration brings hope for glioblastoma treatment Uppsala University Invest","og_description":"Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer.","og_url":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/","og_site_name":"Uppsala University Invest","article_published_time":"2024-12-07T14:12:57+00:00","og_image":[{"width":1024,"height":1004,"url":"https:\/\/uuinvest.se\/wp-content\/uploads\/2024\/12\/croppeduu-1024x1004.jpg","type":"image\/jpeg"}],"author":"Victoria Wouda","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Victoria Wouda","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#article","isPartOf":{"@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/"},"author":{"name":"Victoria Wouda","@id":"https:\/\/uuinvest.se\/#\/schema\/person\/ffa099f10109b4236ca521941d43063e"},"headline":"International research collaboration brings hope for glioblastoma treatment","datePublished":"2024-12-07T14:12:57+00:00","mainEntityOfPage":{"@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/"},"wordCount":1259,"commentCount":0,"image":{"@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/uuinvest.se\/wp-content\/uploads\/2024\/12\/croppeduu.jpg","articleSection":["KNOWLEDGE","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/","url":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/","name":"International research collaboration brings hope for glioblastoma treatment Uppsala University Invest","isPartOf":{"@id":"https:\/\/uuinvest.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#primaryimage"},"image":{"@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/uuinvest.se\/wp-content\/uploads\/2024\/12\/croppeduu.jpg","datePublished":"2024-12-07T14:12:57+00:00","author":{"@id":"https:\/\/uuinvest.se\/#\/schema\/person\/ffa099f10109b4236ca521941d43063e"},"description":"Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer.","breadcrumb":{"@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#primaryimage","url":"https:\/\/uuinvest.se\/wp-content\/uploads\/2024\/12\/croppeduu.jpg","contentUrl":"https:\/\/uuinvest.se\/wp-content\/uploads\/2024\/12\/croppeduu.jpg","width":2000,"height":1961,"caption":"me"},{"@type":"BreadcrumbList","@id":"https:\/\/uuinvest.se\/en\/international-research-collaboration-brings-hope-for-glioblastoma-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/uuinvest.se\/en\/"},{"@type":"ListItem","position":2,"name":"International research collaboration brings hope for glioblastoma treatment"}]},{"@type":"WebSite","@id":"https:\/\/uuinvest.se\/#website","url":"https:\/\/uuinvest.se\/","name":"Uppsala University Invest","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/uuinvest.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/uuinvest.se\/#\/schema\/person\/ffa099f10109b4236ca521941d43063e","name":"Victoria Wouda","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/561e9935b32965fd910374121e60aba0274902d85a35667b02d2e865f0deca86?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/561e9935b32965fd910374121e60aba0274902d85a35667b02d2e865f0deca86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/561e9935b32965fd910374121e60aba0274902d85a35667b02d2e865f0deca86?s=96&d=mm&r=g","caption":"Victoria Wouda"},"url":"https:\/\/uuinvest.se\/en\/author\/victoriawouda\/"}]}},"_links":{"self":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/posts\/5410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/comments?post=5410"}],"version-history":[{"count":8,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/posts\/5410\/revisions"}],"predecessor-version":[{"id":5420,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/posts\/5410\/revisions\/5420"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/media\/5404"}],"wp:attachment":[{"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/media?parent=5410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/categories?post=5410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/uuinvest.se\/en\/wp-json\/wp\/v2\/tags?post=5410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}